PC Pharma PLC reported unaudited earnings results for the first quarter ended June 30, 2013. For the quarter, the company reported revenue of LKR 102,125,793, loss from operating activities of LKR 15,038,985, loss before taxation of LKR 26,406,447 and net loss of LKR 26,406,447 or LKR 0.26 per share against revenue of LKR 161,843,184, profit from operating activities of LKR 21,672,914, profit before taxation of LKR 11,084,107 and net profit of LKR 7,980,557 or LKR 0.08 per share for the same period a year ago. Net cash from operating activities was LKR 18,111,663 against LKR 45,427,237 for the same period a year ago.